(AOF) – Bastide announces that it has been designated by the NHS (National Health Service) as the exclusive operator in respiratory assistance (oxygen therapy) for the East of England region in the United Kingdom. This new contract, lasting 7 years, extendable to 10 years, will bring additional turnover of around 10 million euros per year. The Bastide group will begin operating in this region before the end of 2024, once the administrative and legal phase has been finalized.
Baywater Healthcare is now the exclusive operator in 5 of the 11 UK regions (East of England, North West, West Midlands, Wales, Yorkshire).
Bastide has been present in the United Kingdom in the home respiratory assistance market since the acquisition of Baywater Healthcare in 2018.
This coverage could further expand with the London region, the allocation of which is expected soon, and for which the group had been designated, before the recourse of the operator currently in place.
The French group is consolidating its position as the leading local player, with more than 37,000 patients now receiving oxygen therapy and an annual turnover of around 50 million euros over the full year.
AOF – LEARN MORE
Learn more about the Pharmacy sector
Oncology, priority of pharmaceutical giants
Sanofi’s stock market disappointment recorded at the end of October 2023 underlines the new direction for the group, which has now set oncology as its number 1 priority. Efforts in this segment, where therapies are advancing the fastest, notably involve investments in R&D which weigh on profitability. Sanofi therefore announced a drop in its earnings per share in 2024 and the abandonment of its objective of an operating margin of 32% in 2025. Merck has just unveiled a new alliance. It will pay up to $22 billion to the Japanese group Daiichi Sankyo as part of a partnership on experimental cancer treatments. While some experts estimate that the United States represents nearly half of global oncology spending (drugs and treatments), or $196 billion in 2022, Chinese spending in this area has more than doubled in five years, going from 5 to 11.8 billion dollars.